MRTX : Mirati Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-23 |
|---|---|---|---|---|
| 2023 | $56.06 | $40.02 | $80.52 | 44.61% |
| 2024 | $208.24 | $92.28 | $329.82 | 437.11% |
| 2025 | $430.63 | $353.59 | $475.86 | 1010.73% |
| 2026 | $495.55 | $480.61 | $504.46 | 1178.18% |
| 2027 | $493.58 | $481.54 | $504.53 | 1173.11% |
| 2028 | $480.74 | $480.02 | $481.82 | 1139.97% |
| 2029 | $483.89 | $482.07 | $486.31 | 1148.12% |
| 2030 | $490.48 | $486.92 | $493.49 | 1165.1% |
| 2031 | $493.88 | $493.01 | $494.25 | 1173.87% |
| 2032 | $489.23 | $484.89 | $492.63 | 1161.89% |
| 2033 | $482.64 | $481.4 | $483.84 | 1144.88% |
The 27 Wall Street analysts offering Mirati Therapeutics stock forecast in the last 6 months have average price target of
$74.96 with a high forecast of $121.0 and a low forecast of $50.0.
The average Mirati Therapeutics stock forecast represents a 93.35%
increase from the last price of $38.7700004577637.
From AI system, total return is 2366.52% from 4098 forecasts.
For Mirati Therapeutics stock forecast for 2023, 9 predictions are offered for each month of 2023 with average Mirati Therapeutics stock
forecast of $56.06, a high forecast of $80.52, and a low forecast of $40.02.
The average Mirati Therapeutics stock forecast 2023 represents a 44.61%
increase from the last price of $38.7700004577637.
For Mirati Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Mirati Therapeutics stock
forecast of $208.24, a high forecast of $329.82, and a low forecast of $92.28.
The average Mirati Therapeutics stock forecast 2024 represents a 437.11%
increase from the last price of $38.7700004577637.
For Mirati Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Mirati Therapeutics stock
forecast of $495.55, a high forecast of $504.46, and a low forecast of $480.61.
The average Mirati Therapeutics stock forecast 2026 represents a 1178.18%
increase from the last price of $38.7700004577637.
For Mirati Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Mirati Therapeutics stock
forecast of $480.74, a high forecast of $481.82, and a low forecast of $480.02.
The average Mirati Therapeutics stock forecast 2028 represents a 1139.97%
increase from the last price of $38.7700004577637.
For Mirati Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Mirati Therapeutics stock
forecast of $493.88, a high forecast of $494.25, and a low forecast of $493.01.
The average Mirati Therapeutics stock forecast 2031 represents a 1173.87%
increase from the last price of $38.7700004577637.
For Mirati Therapeutics stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average Mirati Therapeutics stock
forecast of $482.64, a high forecast of $483.84, and a low forecast of $481.4.
The average Mirati Therapeutics stock forecast 2033 represents a 1144.88%
increase from the last price of $38.7700004577637.
Please, see more forecasts below.
MRTX : Mirati Therapeutics stock forecast by Wall Street Analysts
The average Mirati Therapeutics stock forecast from last 6 month is $74.96, and this show a -21.23% decrease in average from the prior price target of the each prediction. Also, this average forecast of $74.96 represents a -42.81% decrease from the past average forecast of $131.08, 6 months ago from 12 wall street analysts.
Mirati Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-27 | $38.37 | -1.04% |
| 2023-03-28 | $37.23 | -2.96% |
| 2023-03-29 | $35.39 | -4.94% |
| 2023-03-30 | $33.76 | -4.59% |
| 2023-03-31 | $34.78 | 3.02% |
MRTX : Long term Mirati Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $40.02 , for 2024 Mar. is $127.50 , for 2027 Mar. is $502.61 , for 2028 Mar. is $480.02 , for 2032 Mar. is $491.70 , and for 2033 Mar. is $481.40.
MRTX : Mirati Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $40.02 | 3.22% |
| 2023 May. | $42.54 | 6.31% |
| 2023 Jun. | $45.70 | 7.42% |
| 2023 Jul. | $49.22 | 7.71% |
| 2023 Aug. | $53.44 | 8.56% |
| 2023 Sep. | $58.04 | 8.61% |
| 2023 Oct. | $63.81 | 9.93% |
| 2023 Nov. | $71.28 | 11.72% |
| 2023 Dec. | $80.52 | 12.96% |
MRTX : Mirati Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $92.28 | 14.61% |
| 2024 Feb. | $107.84 | 16.86% |
| 2024 Mar. | $127.50 | 18.23% |
| 2024 Apr. | $150.18 | 17.79% |
| 2024 May. | $174.12 | 15.94% |
| 2024 Jun. | $199.00 | 14.28% |
| 2024 Jul. | $223.00 | 12.06% |
| 2024 Aug. | $242.14 | 8.58% |
| 2024 Sep. | $262.43 | 8.38% |
| 2024 Oct. | $283.81 | 8.15% |
| 2024 Nov. | $306.74 | 8.08% |
| 2024 Dec. | $329.82 | 7.52% |
MRTX : Mirati Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $353.59 | 7.21% |
| 2025 Feb. | $375.74 | 6.26% |
| 2025 Mar. | $395.58 | 5.28% |
| 2025 Apr. | $411.93 | 4.13% |
| 2025 May. | $425.35 | 3.26% |
| 2025 Jun. | $436.12 | 2.53% |
| 2025 Jul. | $445.09 | 2.06% |
| 2025 Aug. | $452.81 | 1.73% |
| 2025 Sep. | $459.41 | 1.46% |
| 2025 Oct. | $465.30 | 1.28% |
| 2025 Nov. | $470.75 | 1.17% |
| 2025 Dec. | $475.86 | 1.09% |
MRTX : Mirati Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $480.61 | 1.00% |
| 2026 Feb. | $484.60 | 0.83% |
| 2026 Mar. | $488.11 | 0.72% |
| 2026 Apr. | $491.18 | 0.63% |
| 2026 May. | $493.90 | 0.55% |
| 2026 Jun. | $496.29 | 0.48% |
| 2026 Jul. | $498.40 | 0.43% |
| 2026 Aug. | $500.24 | 0.37% |
| 2026 Sep. | $501.81 | 0.31% |
| 2026 Oct. | $503.05 | 0.25% |
| 2026 Nov. | $503.95 | 0.18% |
| 2026 Dec. | $504.46 | 0.10% |
MRTX : Mirati Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $504.53 | 0.01% |
| 2027 Feb. | $504.02 | -0.10% |
| 2027 Mar. | $502.61 | -0.28% |
| 2027 Apr. | $500.21 | -0.48% |
| 2027 May. | $497.28 | -0.59% |
| 2027 Jun. | $494.53 | -0.55% |
| 2027 Jul. | $492.15 | -0.48% |
| 2027 Aug. | $489.95 | -0.45% |
| 2027 Sep. | $487.67 | -0.47% |
| 2027 Oct. | $485.34 | -0.48% |
| 2027 Nov. | $483.18 | -0.45% |
| 2027 Dec. | $481.54 | -0.34% |
MRTX : Mirati Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $480.55 | -0.21% |
| 2028 Feb. | $480.11 | -0.09% |
| 2028 Mar. | $480.02 | -0.02% |
| 2028 Apr. | $480.10 | 0.02% |
| 2028 May. | $480.26 | 0.03% |
| 2028 Jun. | $480.45 | 0.04% |
| 2028 Jul. | $480.66 | 0.04% |
| 2028 Aug. | $480.88 | 0.05% |
| 2028 Sep. | $481.10 | 0.05% |
| 2028 Oct. | $481.33 | 0.05% |
| 2028 Nov. | $481.57 | 0.05% |
| 2028 Dec. | $481.82 | 0.05% |
MRTX : Mirati Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $482.07 | 0.05% |
| 2029 Feb. | $482.33 | 0.05% |
| 2029 Mar. | $482.61 | 0.06% |
| 2029 Apr. | $482.89 | 0.06% |
| 2029 May. | $483.20 | 0.06% |
| 2029 Jun. | $483.52 | 0.07% |
| 2029 Jul. | $483.88 | 0.07% |
| 2029 Aug. | $484.28 | 0.08% |
| 2029 Sep. | $484.72 | 0.09% |
| 2029 Oct. | $485.20 | 0.10% |
| 2029 Nov. | $485.73 | 0.11% |
| 2029 Dec. | $486.31 | 0.12% |
MRTX : Mirati Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $486.92 | 0.13% |
| 2030 Feb. | $487.58 | 0.13% |
| 2030 Mar. | $488.25 | 0.14% |
| 2030 Apr. | $488.94 | 0.14% |
| 2030 May. | $489.64 | 0.14% |
| 2030 Jun. | $490.33 | 0.14% |
| 2030 Jul. | $490.99 | 0.13% |
| 2030 Aug. | $491.61 | 0.13% |
| 2030 Sep. | $492.18 | 0.12% |
| 2030 Oct. | $492.69 | 0.10% |
| 2030 Nov. | $493.13 | 0.09% |
| 2030 Dec. | $493.49 | 0.07% |
MRTX : Mirati Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $493.79 | 0.06% |
| 2031 Feb. | $494.00 | 0.04% |
| 2031 Mar. | $494.15 | 0.03% |
| 2031 Apr. | $494.23 | 0.02% |
| 2031 May. | $494.25 | 0.00% |
| 2031 Jun. | $494.22 | -0.01% |
| 2031 Jul. | $494.14 | -0.02% |
| 2031 Aug. | $494.01 | -0.03% |
| 2031 Sep. | $493.83 | -0.04% |
| 2031 Oct. | $493.60 | -0.05% |
| 2031 Nov. | $493.33 | -0.06% |
| 2031 Dec. | $493.01 | -0.07% |
MRTX : Mirati Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $492.63 | -0.08% |
| 2032 Feb. | $492.19 | -0.09% |
| 2032 Mar. | $491.70 | -0.10% |
| 2032 Apr. | $491.15 | -0.11% |
| 2032 May. | $490.54 | -0.12% |
| 2032 Jun. | $489.88 | -0.14% |
| 2032 Jul. | $489.17 | -0.15% |
| 2032 Aug. | $488.41 | -0.15% |
| 2032 Sep. | $487.61 | -0.16% |
| 2032 Oct. | $486.76 | -0.17% |
| 2032 Nov. | $485.86 | -0.19% |
| 2032 Dec. | $484.89 | -0.20% |
MRTX : Mirati Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $483.84 | -0.22% |
| 2033 Feb. | $482.68 | -0.24% |
| 2033 Mar. | $481.40 | -0.27% |
Frequently Asked Questions about Mirati Therapeutics stock forecast
Is Mirati Therapeutics a good long term stock?
From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2023 Apr. is $40.0166852908649 From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2024 Mar. is $127.49952376294 From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2027 Mar. is $502.611402255623 From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2028 Mar. is $480.018801736048 From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2032 Mar. is $491.70323369775 From Mirati Therapeutics stock forecast , Mirati Therapeutics (MRTX) stock can be a good investment choice. According to Tudal, the Mirati Therapeutics stock price forecast for 2033 Mar. is $481.396538135551
Is Mirati Therapeutics stock overvalued?
Mirati Therapeutics (MRTX) stock is expected to go UP . Therefore, Tudal would say that Mirati Therapeutics (MRTX) stock is NOT overvalued.
Will Mirati Therapeutics stock price go up?
Yes. The Mirati Therapeutics stock price forecast for 2024 Mar. is $127.49952376294
Is Mirati Therapeutics stock a good buy now?
Since closing price on 2023-03-23 is $38.7700004577637 and forecast for 2024 Mar. is $127.50, Mirati Therapeutics stock is a good 1 year investment.